
OraSure Technologies OSUR
$ 3.01
0.0%
Annual report 2025
added 03-09-2026
OraSure Technologies EV/EBITDA Ratio 2011-2026 | OSUR
Annual EV/EBITDA Ratio OraSure Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 361 | 254 | 24.2 | 19.2 | 35.9 | 14.4 | 15.6 | -105 | -17.3 | -30.3 | -112 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 361 | -112 | 41.8 |
EV/EBITDA Ratio of other stocks in the Medical instruments industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
25.8 | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
15.9 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
-0.0238 | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
72.7 | $ 75.4 | -0.8 % | $ 40.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
0.307 | $ 11.21 | -1.41 % | $ 27.2 M | ||
|
The Cooper Companies
COO
|
34.6 | $ 63.09 | -1.94 % | $ 12.6 B | ||
|
Antares Pharma, Inc.
ATRS
|
44 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
24.9 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
6.47 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
14.8 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
252 | - | -0.02 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
23.5 | $ 121.01 | -1.5 % | $ 2.98 B | ||
|
iRhythm Technologies
IRTC
|
-38.7 | $ 125.44 | -0.41 % | $ 4.01 B | ||
|
Haemonetics Corporation
HAE
|
12.9 | $ 59.84 | -1.06 % | $ 3.01 B | ||
|
electroCore
ECOR
|
1.45 | $ 6.15 | 1.32 % | $ 52.2 K | ||
|
Repro Med Systems
KRMD
|
-17.1 | $ 4.08 | 0.49 % | $ 188 M | ||
|
Isoray
ISR
|
18.4 | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
49.3 | $ 466.64 | -0.92 % | $ 167 B | ||
|
Microbot Medical
MBOT
|
-2.17 | $ 2.1 | -3.23 % | $ 96.2 M | ||
|
Glaukos Corporation
GKOS
|
-908 | $ 119.63 | -2.0 % | $ 5.79 B | ||
|
Milestone Scientific
MLSS
|
-7.89 | $ 0.33 | -4.15 % | $ 27.1 M | ||
|
Masimo Corporation
MASI
|
40.8 | $ 178.51 | -0.08 % | $ 9.51 B | ||
|
InfuSystem Holdings
INFU
|
15.8 | $ 10.18 | -4.5 % | $ 210 M | ||
|
Merit Medical Systems
MMSI
|
25 | $ 66.74 | -1.02 % | $ 3.95 B | ||
|
Envista Holdings Corporation
NVST
|
15.7 | $ 26.49 | -1.05 % | $ 4.45 B | ||
|
Pulse Biosciences
PLSE
|
-5.21 | $ 21.83 | -3.62 % | $ 1.47 B | ||
|
Retractable Technologies
RVP
|
3.35 | $ 0.62 | -2.99 % | $ 18.6 M | ||
|
Pro-Dex
PDEX
|
20.7 | $ 51.51 | -0.87 % | $ 169 M | ||
|
LeMaitre Vascular
LMAT
|
22.8 | $ 112.4 | -1.85 % | $ 2.54 B | ||
|
STAAR Surgical Company
STAA
|
89 | $ 26.7 | 0.07 % | $ 1.32 B | ||
|
STERIS plc
STE
|
29.7 | $ 219.75 | -1.1 % | $ 21.7 B | ||
|
Predictive Oncology
POAI
|
1.29 | - | - | $ 31.1 M | ||
|
Teleflex Incorporated
TFX
|
21.2 | $ 135.52 | 0.33 % | $ 6.05 B | ||
|
BioLife Solutions
BLFS
|
-38.3 | $ 20.9 | -2.38 % | $ 963 M | ||
|
Stereotaxis
STXS
|
-28.2 | $ 1.86 | -3.63 % | $ 169 M | ||
|
Baxter International
BAX
|
24.7 | $ 17.94 | -2.97 % | $ 9.2 B | ||
|
ResMed
RMD
|
35.2 | $ 217.14 | -2.2 % | $ 31.7 B | ||
|
AtriCure
ATRC
|
48.1 | $ 28.48 | -1.93 % | $ 1.36 B | ||
|
Utah Medical Products
UTMD
|
14.1 | $ 66.61 | -0.25 % | $ 216 M | ||
|
Harvard Bioscience
HBIO
|
70.9 | $ 6.45 | -5.56 % | $ 286 M | ||
|
NeuroMetrix
NURO
|
-2.11 | - | 5.05 % | $ 9.02 M | ||
|
West Pharmaceutical Services
WST
|
33.1 | $ 292.13 | -3.33 % | $ 21.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
11.9 | $ 11.78 | -1.51 % | $ 2.35 B | ||
|
AngioDynamics
ANGO
|
-102 | $ 10.98 | -0.99 % | $ 449 M | ||
|
Becton, Dickinson and Company
BDX
|
13.6 | $ 149.52 | -0.47 % | $ 43 B | ||
|
Nephros
NEPH
|
-8.71 | $ 3.32 | 2.79 % | $ 34.5 M | ||
|
Repligen Corporation
RGEN
|
70.6 | $ 117.43 | -0.73 % | $ 6.54 M |